US Patent No. 9,371,553

Genetically modified mice that produce hybrid antibodies
Jun 23, 2016

Regeneron Pharmaceuticals has been awarded US Patent No. 9,371,553, "Genetically modified mice that produce hybrid antibodies."

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.